Boris Jordan

Lots of good information and lots of misinformation is swirling around about the future viability of cultivated meat. The former owner of Daniele prosciutto and now cultivated meat investor, Davide Dukcevich discusses the outlook for cultivated meat AND the outlook for meat. Tune in and bring your questions. #meat #cultivatedmeat #investing #impactinvesting

9

We are #live in #5 on The Plantbased Business Hour with Elysabeth Alfano to discuss VegTech Invest white paper with Harvard students on Stakeholder Engagement in Plant-based Innovation & Diversified Proteins. Chief Investment Officer Sasha Goodman joins in to discuss the top 5 findings and why they are important. Bring your questions here to this page in 5, 4, 3, 2.... and download the paper at https://lnkd.in/g8KKjsb2 #whitepaper #stakeholderengagement Gwendolyn Brown

3

The Capital Access for Seed & Early Stage Investments Vs Later Stage Investments; ---> Roll Call for International Partners wanting to Add Value in the Region. https://hubs.ly/Q02CLVS90

1

I love this! Thank you to Rachel Brown from Beauty Independent to kick-off this exchange with Andrew Ross' provocative thesis and have us all react to it. I truly enjoyed reading everyone's thoughts on the topic of the shortening lifecycle of beauty brands. Here is a snippet of mine: "Because beauty brand lifespans are shortening, it is important that we are able to differentiate brands with staying power from brands that will end up being a flash in the pan. There are much more of the latter than the former in the market right now, and if a brand is not well-positioned, it will be challenging for that brand to survive over the long-term. That’s why we focus on understanding each brand’s differentiators and long-term relevance." See more here: https://lnkd.in/esVbwnu2 and you will discover what Kevin Murphy, Odile Roujol, Rich Gersten, Tina Henry Bou-Saba, Oliver Nordlinger, Claire Chang, Manica Blain, Sonya Brown, George Birman had to say. #beautyindustry #beautyinvesting Stride Consumer Partners

11

4 Comments

I'm looking forward to moderating a panel on June 17th at the Future Food-Tech Alt Protein Conference titled: "Boosting Investor Confidence: Adapting Innovative Financing Models to Overcome the Trough of Disillusionment" ___________________________________________________________________ I'll be joined by a great group of investors in the space, including: Shayna Harris of Supply Change Capital Ashley Hartman of Bluestein Ventures Nadav Berger of PeakBridge Rosie Wardle of Synthesis Capital We plan to hit on various topics: 🔵 Current fundraising environment for alt protein companies 🔵 How this varies by stage 🔵 What investors are looking for that help a company stand out 🔵 What needs to change in the space 🔵 Innovative financing approaches being taken beyond VC 🔵 and more Should be a great discussion, and I'm looking forward to hearing questions from the audience as well - from startups to corporates to other investors - hoping to get questions about what's really on everyone's minds If you'll be at the conference, let me know, as I'd love to connect! 💻 PS: If you were wondering what AI Image Generators create if you type in "Boosting Investor Confidence in Alternative Proteins" the pic below is one of the ones you get. Good? Bad? Odd? Not sure - but who knows what actually goes on within AI

79

20 Comments

NY friends! Please come see me at Tech Day on my panel discussing the future of the NY tech ecosystem and what I hope to bring to it!

72

5 Comments

It's Earth Month 🌎 and Clear Current Capital's portfolio company, Nosh.bio stands out for truly embodying the ethos of "Think Different." Founders Tim Fronzek and Felipe Lino prioritize core values such as trust, respect, pro-activity, customer-centricity, and positive thinking in shaping their company culture 💫. With a diverse team spanning nine nationalities and four continents, they understand the unifying power of food 🌱. Through scalable and sustainable technology, Nosh aims to provide clean, healthy, and affordable food. They are not only thinking but building, nourishing, and solving problems differently, particularly concerning the longevity and strength of our food system. Be inspired to Think Different. 🍎 Challenge: Many food products are not tasty, affordable, or sustainable. CLEAR + BOLD SOLUTION: Nosh.bio creates ingredients from fungi for cleaner labels, improved taste, and texture in meat and fish analogues, as well as convenience foods, dairy, confectionery, and bakery items while adding nutritional value. Their nutritional and highly functional proteins are naturally produced, low processed, allergen-free, non-GMO, not novel foods, and at cost parity. Nosh's proprietary fermentation process is scalable and sustainable. #innovation #food #foodtech #sustainability #climatesolutions #EarthMonth

27

3 Comments

NY Climate Tech Founders! 1) YES PLEASE save the date to join us at #techweek (6/3!), and 2) YES PLEASE share your top NY resources to complete our NY INSIDER GUIDE, in collab with NYCEDC!

11

📈🏢 Aby Rosen's RFR Holding is facing a staggering $2.5B debt bill as defaults pile up! 💥 🔎 According to a recent Bisnow article, RFR Holding, a prominent NYC real estate firm, is grappling with mounting debt and defaults. The company, led by billionaire Aby Rosen, has a portfolio of high-profile properties, including the iconic Seagram Building and Lever House. 🏢🏦 📊 The firm's debt load has surged to a whopping $2.5B, with $1.1B in loans maturing this year alone. 💸 The pandemic has hit the commercial real estate market hard, causing defaults to skyrocket. RFR Holding is no exception, with defaults on several properties, including the $200M mortgage on the Seagram Building. 📉 🗣️ "The pandemic has created a perfect storm for commercial real estate," said one industry expert. "Companies like RFR Holding are facing unprecedented challenges as they navigate this difficult time." 🌪️ 🔜 So, what's next for RFR Holding? The company is reportedly exploring options to refinance its debt and avoid further defaults. 💡 With the commercial real estate market showing signs of recovery, there's hope that RFR Holding can weather this storm. 🌞 Stay tuned for more updates on this developing story! 📰🔔 #RFRHolding #CommercialRealEstate #Debt #Defaults #NYCRealEstate

5

Boards of Directors – How Relevant To The Business Is The Board? In 2014, activist investor Starboard Value successfully replaced all 12 directors on the board of Darden Restaurants. The following shows the Darden incumbent board at the time of Starboard's proxy fight, Starboard’s value creation plan initiatives, the Starboard director nominees and the before and after performance (revenue, EBITDA, EBITDA margin and stock price). Note especially the direct relevance of each Starboard nominee to the industry or some aspect of the value creation plan. How often do you see this level of relevance on public company boards?

11

13 Comments

PE - Hedge Funds Hit by Lack of PE Exits (and one way that PE firms can boost exits) Financial Times: https://lnkd.in/edACss_X FYI - one way to get more PE exits is for the PE fund to have a domain expertise GTM and have deep knowledge on how to increase the Revenue Growth of portfolio companies which boosts cash, profits and margins. --- #pe #privateequity #business

24

4 Comments

Throw back Thursday! 😊Excited to look back at 2023 through the publication of our Catalyst Fund Impact Report! The report spotlights the hard work of our portfolio companies after a year of work with them, as they continue to build game-changing solutions from precision agriculture technologies to water access solutions or waste management tools. 👉 Dive into our portfolio companies' impact to date, our theory of change, and how we empower bold founders to build a climate-resilient future for millions of Africans. 👉 Learn about our gender lens investing approach, sustainability focus, and how our startups are driving green growth and positioning Africa as a leader in climate action. 👉 Explore spotlights on select portfolio companies and discover how Catalyst Fund's hands-on venture building accelerates the path to scale for early-stage climate tech in Africa 👉 See the recognition our fund has earned to date and join us in investing for a climate-resilient future on the continent. Sand to Green, Bekia inc, Visual and AI Solutions (VAIS), Assuraf | Insurance, Simply, Eight Medical | Techstars ‘23, Farmz2U, Farm to Feed, Octavia Carbon, PaddyCover, Agro Supply, NoorNation, Scrapays, THOLA, Earthbond, Zebra CropBank, Medikea, Keep IT Cool, Tolbi Link to download the report: https://lnkd.in/ejJjH6aD

34

8 Comments

As the Shasta Ventures approval deadline approaches, we're presented with a unique opportunity to observe the complexities and inherent conflicts in GP-led secondary transactions. This scenario sheds light on the considerable leverage GPs hold within the private equity infrastructure. According to the article, proposed continuation fund requires LPs to approve the transaction if they wish to roll their interests into the new structure—a stipulation that could be seen as putting undue pressure on LPs. This raises critical questions about the balance of power in private equity deals and the alignment of interests between GPs and LPs. What are your thoughts? Is it appropriate for GPs to demand such conditions for LPs to participate in a continuation fund? How do you see this impacting the broader private equity landscape and the perception of GP-led secondary transactions? Looking forward to hearing your insights and perspectives on this pivotal issue. #PrivateEquity #VentureCapital #InvestmentTrends #ShastaVentures #GPledSecondaries

3

2 Comments

🌍🌳 New Episode Alert! Dive into Nature-Based Solutions with World Tree🌳🌍 In this episode of Investor Connect, host Hall T. Martin sits down with Doug Willmore, CEO, and Cathy Key, President & Chief Business Development Officer of WorldTree. Listen here: https://ow.ly/QOqe50SbVGx Join the conversation to explore: 🌲 The journey from a small startup to managing 300 tree farms across multiple countries. 💡 Cathy’s intriguing shift from anthropology to tech, redefining WorldTree's business model. 💸 Doug’s update on their current fundraising efforts and ambitious goals ahead. 📊 Insights into WorldTree’s revenue streams, valuation approach, and strategies for attracting the right investors. 🌐 Hall's innovative approaches at Ten Capital for connecting with potential investors. Discover how WorldTree is tackling global challenges with nature-based solutions, focusing on people, planet, and prosperity. 🌎✨ 🔗 Learn more about WorldTree and their sustainable initiatives: https://ow.ly/WZyW50SbVGy Don't miss this treasure trove of insights for anyone navigating the startup funding landscape! 🎧 #InvestorConnect #WorldTree #NatureBasedSolutions #SustainableBusiness #StartupFunding #EcoFriendly #GreenBusiness #Podcast

4

1 Comment

🔍 Considering a sale in an economic downturn? Read Gerald O'Dwyer III's latest article to understand the pros and cons: https://buff.ly/3z9DY8q 📈 Learn more about Blackmore Partners: https://buff.ly/42iNmB3 ❓ Have questions? Schedule a meeting with our Director Chris Melton here: https://buff.ly/4cpKqHv #Articles #PrivateEquityInsights #PE #PrivateEquity #BlackmorePartners

6

Our partner Eddie Eltoukhy has identified these opportunities in Biotech. Eddie has a PhD in bioengineering from Massachusetts Institute of Technology and over a decade experience as an operator. Reach out to him if you are working on these areas of biotech. Pear VC - Technology-Driven Therapeutic Platforms Companies developing therapeutic assets with a core product engine Proprietary tool, workflow, or samples leading to novel biological data sets Preference for omics platforms or high throughput screening / engineering workflows First-in-class or best-in-class drugs - Next-Generation Therapeutic Modalities Technologies to improve the efficacy, safety, access, or reach of next-gen modalities including the following: Genomic medicines (gene tx & gene editing) Cell therapies Targeted protein degraders Antibody-drug conjugates Radiopharma - Precision Medicine New technologies supporting the discovery of novel biomarkers and the generation of proprietary data sets for applications in: Disease screening Therapy selection Recurrence monitoring - Life Sciences + AI Software Platforms Software & AI-driven platforms to improve all aspects of life sciences R&D, including: Target discovery and validation Drug design and optimization Manufacturing Regulatory Clinical development

120

5 Comments

The consolidation play by Private Equity has both pros and cons, and it cannot be denied that sometimes the consumer may suffer, but the quality of the provision may become higher. It's a trade-off that needs to be managed well in order for it not to become "vampire economics" #PrivateEquity #VentureCapital #ImpactInvesting #Economy #USEconomy #Investing https://lnkd.in/gtdk6d5v

7

As private markets welcome more investors to the space, the how becomes as important as the why. iCapital Chairman & CEO Lawrence Calcano came on the Alt Goes Mainstream podcast to break down the how and the why. How can investors gain access to private markets in ways that work for them? How can alternative asset managers better serve those investors? How can this all be done in a responsible, thoughtful way that sets up both investors and private markets for success in the long-term? What is the evolution of the different service models that enable GPs to unlock access to private markets for more LPs? Lawrence Calcano and I discussed these topics and more on the show. Thanks Lawrence for coming on the show to share your thoughtful perspectives on the industry and its continued evolution. Thanks to Ultimus Fund Solutions for sponsoring this episode of the Alt Goes Mainstream podcast. https://lnkd.in/eX7njq8b

28

2 Comments

Prime Coalition has long taken a different tack to climate finance compared to its for-profit brethren. It makes the usual venture-style investments in startups through Azolla Ventures and also helps philanthropists direct their money to climate-related projects that it deems high impact. Trellis Climate follows the latter model with a focus on middle stages, where capital has grown scarce. #climatetech #climateVC #climatefinance

14